Prevention of ischemic injury and early reperfusion derangements by hypothermic retroperfusion

Hypothermic synchronized retroperfusion was applied during coronary artery occlusion to determine its ability to alleviate junctional derangements of reperfusion and to reduce infarct size. The proximal left anterior descending coronary artery was occluded in 25 closed chest dogs for 3 hours and then reperfused for 7 days. Thirteen dogs with no reperfusion pretreatment served as a control group (Group A). In 12 dogs, hypothermic retroperfusion was applied from 30 minutes up to 3 hours of the occlusion period (Group B). Sequential two-dimensional echocardiographic and hemodynamic as well as metabolic measurements were performed. Compared with untreated control dogs, dogs with hypothermic synchronized retroperfusion had significantly reduced heart rate and rate-pressure product, decreased left ventricular volumes and improved ejection fraction during the occlusion period. Two-dimensional echocardiographically-derived ischemic zone systolic fractional area change and systolic wall thickening indicated significantly improved function as a result of retroperfusion. During the reperfusion period, untreated control dogs (group A) had more severe derangements in hemodynamics and wall motion than dogs treated by hypothermic retroperfusion (group B). Mortality was 30.7% in group A, 16.7% in group B and 7th day infarct size as percent of the left ventricle was 12.0 +/- 6.5 (mean +/- standard deviation) and 4.2 +/- 5.9, respectively (p less than 0.02). It is concluded that hypothermic synchronized retroperfusion applied after coronary occlusion and before reperfusion significantly improves cardiac function during occlusion, minimizes complications of reperfusion and reduces the ultimate infarct size. Because this form of circulatory assistance helps maintain cardiac function and delays the evolution of myocardial necrosis, its application may be beneficial during an evolving acute myocardial infarction before achievement of surgical or nonsurgical reperfusion.

This article has been cited by other articles:

				B. M. Stegman, L. K. Newby, J. S. Hochman, and E. M. Ohman Post-Myocardial Infarction Cardiogenic Shock Is a Systemic Illness in Need of Systemic Treatment: Is Therapeutic Hypothermia One Possibility? J. Am. Coll. Cardiol., February 14, 2012; 59(7): 644 - 647. [Abstract] [Full Text] [PDF]

				R. Tissier, B. Ghaleh, M. V. Cohen, J. M. Downey, and A. Berdeaux Myocardial protection with mild hypothermia Cardiovasc Res, December 26, 2011; (2011) cvr315v2. [Abstract] [Full Text] [PDF]

				S. L. Hale and R. A. Kloner Mild Hypothermia as a Cardioprotective Approach for Acute Myocardial Infarction: Laboratory to Clinical Application Journal of Cardiovascular Pharmacology and Therapeutics, June 1, 2011; 16(2): 131 - 139. [Abstract] [PDF]

				R. Tissier, M. Chenoune, B. Ghaleh, M. V. Cohen, J. M. Downey, and A. Berdeaux The small chill: mild hypothermia for cardioprotection? Cardiovasc Res, December 1, 2010; 88(3): 406 - 414. [Abstract] [Full Text] [PDF]

				H. L. Lazar Coronary Sinus Interventions during Cardiac Surgery Ann. Thorac. Surg., October 1, 1988; 46(4): 475 - 482. [Abstract] [PDF]